A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...
A major feature of Parkinson’s disease is the loss of dopamine-producing cells in the brain. As dopamine levels decline, it becomes more difficult for the brain to control movement. ADHD is a ...
Parkinson’s disease (PD) affects nearly 2% of adults over 65, making it the second most common neurodegenerative disorder. It ...
Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease ... have found a way to better control the preclinical generation of key neurons depleted in Parkinson's disease ...
A photothermal, nanoparticle-based deep brain stimulation system restored motor skills in mice with Parkinson’s-like disease ...
A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...
Nerve cells use a brain chemical called dopamine to help control muscle movement ... fibroblasts in adult humans and Parkinson’s disease patients. Such neurons survived transplantation into ...
Parkinson’s disease is a neurodegenerative disorder that affects millions of people worldwide, causing a range of motor and ...
Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical role in the development of ... the death of dopamine neurons.
Researchers at Wuhan University have discovered a cholesterol metabolite that may play a critical role in the development of Parkinson ... and damage to the dopamine neurons in the critical ...
Parkinson's Patients Have Improved Motor and Non-Motor Function After Treatment with Theralase(R) Cool Laser TherapyToronto, ...
Cell replacement for Parkinson’s disease replaces the dopamine neurons lost to degeneration and can restore dopaminergic function in the brain, providing a completely new treatment modality ...